Alaspan AM Tablet (Loratadine & Ambroxol Hydrochloride)

Alaspan AM Tablet is a high-potency pharmacological intervention specifically engineered for the clinical management of productive cough associated with allergic rhinitis, bronchospasm, and chronic inflammatory airway diseases. Utilizing a unique “Dual-Path” delivery system, this formulation works by concurrently modulating the organized inhibition of peripheral H1-histamine receptors and reinforcing the structural integrity of the respiratory mucosa through specialized mucolytic action. By neutralizing the biochemical triggers of allergic inflammation and facilitating the organized clearance of tenacious secretions, Alaspan AM effectively promotes a significant increase in pulmonary airflow and a reduction in metabolic dullness. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the respiratory matrix while promoting a stable, physiological recovery from environmental and microbial stressors.

Key Features

Specifically formulated with an antihistamine and a mucolytic to target the primary pathways of respiratory hypersensitivity and secretion stasis.
Clinically recognized for its role in facilitating the natural optimization of surfactant production and bronchial clearance.
Specifically engineered to reach therapeutic levels within the plasma, ensuring a robust defense against localized allergic mediators.
Acts as a functional catalyst to stabilize the bronchial environment and support the reduction of congestion-related fatigue.
Formulated to address respiratory fatigue without compromising cognitive alertness, facilitating a stable restoration cycle.

Key Ingredients

Loratadine (5mg)
Ambroxol Hydrochloride (60mg)
Microcrystalline Cellulose
Magnesium Stearate
Lactose Monohydrate

Precautions

This is a high-potency pharmacological intervention. Consult with a specialist prior to use to ensure a formal understanding of your baseline respiratory state.
Inform your physician if you have a history of impaired liver or kidney function, as dosage adjustments may be required to maintain physiological safety.
Use with caution in individuals with a history of peptic ulceration due to the mucolytic effect of Ambroxol on the gastric protective barrier.
Discontinue use immediately if persistent localized cutaneous eruptions, severe gastrointestinal upset, or angioedema occur during the treatment period.
Consult a healthcare provider before administration during pregnancy or lactation to ensure the physiological safety of the restoration cycle.
Keep the pack tightly sealed and store in a cool, dry place (below 30°C). Protect from moisture and direct light to maintain the molecular stability of the active constituents.

How to Use

The tablet should be swallowed whole with a glass of water. Do not crush or chew to ensure the intended systemic delivery.
Typically, one tablet once or twice daily constitutes the standard therapeutic dose for the restoration of respiratory equilibrium, as dictated by clinical requirements.
For optimal clinical results, administration should occur at regular intervals as part of your primary wellness regimen.
Ensure the oral cavity is ready for the intake of active agents. Maintain adequate systemic hydration to facilitate the intended mucolytic response.
Use as a standalone treatment or as part of a comprehensive respiratory plan including environmental allergen avoidance.
Maintain a regular application schedule to document visible improvements in physiological markers and the restoration of systemic health.

Legal Disclaimer: Alaspan AM Tablet is a specialized pharmacological product. Individual results vary based on the patient’s baseline physiological state and response. This product is for use under professional guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.